First line chemotherapy responsiveness and patterns of metastatic spread identify clinical syndromes present within advanced KRAS mutant non-small cell lung cancer with different prognostic significance

PURPOSE: Unsuccessful KRAS-specific treatment approaches in non-small cell lung cancer (NSCLC) may reflect underlying disease heterogeneity. We sought to define clinical ‘syndromes’ within advanced KRAS mutant NSCLC to improve future clinical trials and create a clinical framework for future molecul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lung Cancer
Main Authors: Iams, Wade T., Yu, Hui, Shyr, Yu, Patil, Tejas, Horn, Leora, McCoach, Caroline, Kelly, Karen, Doebele, Robert C., Camidge, D. Ross
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204301/
https://ncbi.nlm.nih.gov/pubmed/30197261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2018.08.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados